DK167599B1 - Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme - Google Patents

Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme Download PDF

Info

Publication number
DK167599B1
DK167599B1 DK125887A DK125887A DK167599B1 DK 167599 B1 DK167599 B1 DK 167599B1 DK 125887 A DK125887 A DK 125887A DK 125887 A DK125887 A DK 125887A DK 167599 B1 DK167599 B1 DK 167599B1
Authority
DK
Denmark
Prior art keywords
equi
strain
vaccine
horses
avirulent
Prior art date
Application number
DK125887A
Other languages
Danish (da)
English (en)
Other versions
DK125887D0 (da
DK125887A (da
Inventor
John F Timoney
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of DK125887D0 publication Critical patent/DK125887D0/da
Publication of DK125887A publication Critical patent/DK125887A/da
Application granted granted Critical
Publication of DK167599B1 publication Critical patent/DK167599B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK125887A 1985-07-12 1987-03-11 Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme DK167599B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75461385A 1985-07-12 1985-07-12
US75461385 1985-07-12
PCT/US1986/001460 WO1987000436A1 (en) 1985-07-12 1986-07-14 The protection of equines against streptococcus equi
US8601460 1986-07-14

Publications (3)

Publication Number Publication Date
DK125887D0 DK125887D0 (da) 1987-03-11
DK125887A DK125887A (da) 1987-03-11
DK167599B1 true DK167599B1 (da) 1993-11-29

Family

ID=25035573

Family Applications (1)

Application Number Title Priority Date Filing Date
DK125887A DK167599B1 (da) 1985-07-12 1987-03-11 Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme

Country Status (18)

Country Link
US (1) US5183659A (de)
EP (1) EP0230456B1 (de)
JP (1) JPH0816064B2 (de)
AR (1) AR241545A1 (de)
AT (1) ATE71532T1 (de)
AU (1) AU604645B2 (de)
CA (1) CA1281287C (de)
DE (1) DE3683478D1 (de)
DK (1) DK167599B1 (de)
ES (1) ES2000491A6 (de)
FI (1) FI87530C (de)
GR (1) GR861795B (de)
IE (1) IE58964B1 (de)
NO (1) NO169997C (de)
NZ (1) NZ216796A (de)
PT (1) PT82971B (de)
WO (1) WO1987000436A1 (de)
ZA (1) ZA865156B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2523883Y2 (ja) * 1992-02-24 1997-01-29 株式会社三協精機製作所 プーリ付調速器
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
WO1998058945A1 (en) 1997-06-24 1998-12-30 Timoney John F Compounds encoding the protective m-like protein of streptococcus equi and assays therefor
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
US20070059327A2 (en) * 1998-01-15 2007-03-15 Wyeth Streptococcus equi compositions and methods of use
DE60007668T2 (de) * 1999-01-26 2004-12-02 Akzo Nobel N.V. Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes
DK1560594T3 (da) 2002-10-11 2010-10-04 Bengt Guss Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi
JP2011506433A (ja) 2007-12-13 2011-03-03 インターバック アーベー 改変された免疫組成物
CA2799136A1 (en) 2010-05-26 2011-12-01 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
RU2016114713A (ru) 2013-10-17 2017-11-20 Зоэтис Сервисиз Ллс Способы и композиции для лечения s. equi инфекции
KR101694676B1 (ko) * 2015-12-10 2017-01-10 우진 비앤지 주식회사 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3793150A (en) * 1971-01-20 1974-02-19 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
US3852420A (en) * 1971-01-20 1974-12-03 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
JPS60251898A (ja) * 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine

Also Published As

Publication number Publication date
ES2000491A6 (es) 1988-03-01
AU604645B2 (en) 1991-01-03
ZA865156B (en) 1987-05-27
IE861852L (en) 1987-01-11
WO1987000436A1 (en) 1987-01-29
DE3683478D1 (de) 1992-02-27
FI87530C (fi) 1993-01-25
PT82971A (pt) 1986-08-01
NZ216796A (en) 1991-11-26
US5183659A (en) 1993-02-02
NO871012D0 (no) 1987-03-11
AR241545A1 (es) 1992-08-31
EP0230456A1 (de) 1987-08-05
DK125887D0 (da) 1987-03-11
FI87530B (fi) 1992-10-15
GR861795B (en) 1986-11-11
AU6149686A (en) 1987-02-10
FI871060A (fi) 1987-03-11
EP0230456B1 (de) 1992-01-15
NO871012L (no) 1987-03-11
JPH0816064B2 (ja) 1996-02-21
EP0230456A4 (de) 1987-10-27
JPS63500596A (ja) 1988-03-03
IE58964B1 (en) 1993-12-01
CA1281287C (en) 1991-03-12
DK125887A (da) 1987-03-11
NO169997C (no) 1992-09-02
ATE71532T1 (de) 1992-02-15
FI871060A0 (fi) 1987-03-11
PT82971B (pt) 1988-07-01
NO169997B (no) 1992-05-25

Similar Documents

Publication Publication Date Title
Fekadu et al. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses
DK167599B1 (da) Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme
Zygmunt et al. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep
AU621288B2 (en) Vaccine against pasteurella
Timoney et al. The protective M proteins of the equine group C streptococci
Söderlind et al. Effect of parenteral vaccination of dams on intestinal Escherichia coli in piglets with diarrhea
Groschup et al. Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae
CA1331445C (en) Vaccine against e. coli septicaemia in poultry
Yamaguchi et al. Isolation and characterization of a Haemophilus paragallinarum mutant that lacks a hemagglutinating antigen
Sakano et al. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type A P. multocida
De Cueninck et al. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide
Mosier et al. Passive protection of calves with Pasteurella haemolytica antiserum
Frandsen et al. Characterization of toxin from different strains of Pasteurella multocida serotype A and D
Rimler Passive immune cross-protection in mice produced by rabbit antisera against different serotypes of Pasteurella multocida
Loftager et al. Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2
McKinney et al. Pasteurella haemolytica: purification of saline-extractable proteins by isoelectrofocusing
Elsheikh et al. Induction of protective immune response by vaccination against Pseudomonas pneumonia of mink
Shin et al. A predictive model for the level of sIgA based on IgG levels following the oral administration of antigens expressed in Sacchromyces cerevisiae
BARBOUR et al. Induction of Early Immunopotentiation to Fimbriae of Salmonella Enteritidis (SE) by Administering Thymulin and Zinc to SE-Vaccinated Chicken Breeders
Woods et al. Purification and serological characterization of a type-specific antigen of Streptococcus equisimilis
Kumar et al. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139
AU619908B2 (en) Bacterial strains
Karaca et al. An inactivated temperature‐sensitive mycoplasma gallisepticum mutant for protection against airsacculitis
Beetham IgG and IgA in turkeys vaccinated with pasteurella multocida measured by ELISA
Osek Oral immunization of piglets with Escherichia coli vaccine. I. Serum antibodies

Legal Events

Date Code Title Description
PUP Patent expired